According to a new report North America Urinary Incontinence Devices Market, published by KBV research, the North America Urinary Incontinence Devices Market would witness market growth of 10.3% CAGR during the forecast period (2018 – 2024).
The USA market would dominate the North America Vaginal Slings Market by 2024, growing at a CAGR of 9.6 % during the forecast period. The Canada market is expected to witness a CAGR of 11.8% during (2018 - 2024). Additionally, The Mexico market is expected to witness a CAGR of 11.6% during (2018 - 2024).
The Internal Urinary Incontinence Devices market dominated the North America Urinary Incontinence Devices Market by Category in 2017 achieving a market value of $795.6 million by 2024. The External Urinary Incontinence Devices market is expected to witness a CAGR of 11.6% during (2018 - 2024).
The Stress Incontinence market would dominate the Canada Urinary Incontinence Devices Market by 2024. The Urge Incontinence market is expected to witness a CAGR of 12.3% during (2018 - 2024).
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of C. R. Bard, Inc., Boston Scientific Corporation, Coloplast Group, Medtronic plc, Ethicon US, LLC. (Johnson & Johnson), B. Braun Melsungen AG, Teleflex Incorporated, Atlantic Therapeutics, and Zephyr Surgical Implants
By Incontinence Type
Unique Offerings from KBV Research